Drugs / NovoMix® 30 Penfill®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04184492 Comparator | Apr → Jun 2019 | — | Geropharm | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NovoMix 30 Penfill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04184492 ↗ |
| Route | Subcutaneous | “Single subcutaneous administration of NovoMix® 30 Penfill®” NCT04184492 ↗ |